Executive Committee

Xueyi Li

Xueyi Li is Assistant Professor of Neurology at Massachusetts General Hospital and Harvard Medical School. He was trained as a physician in China, a cell biologist in Germany, and a neurobiologist in US. Dr. Li studies how cells in our body process proteins for reuse. In most cases, protein reuse occurs through a process called endocytic recycling. Aberrance associated with this protein recycling process has been linked to many human diseases including cancer and autism. A major focus of Dr. Li’s research is to decipher how protein recycling is controlled in cells and to find ways for harnessing protein recycling as disease therapy and or disease diagnosis. Dr. Li’s laboratory has created several lines of genetically modified mice to facilitate studies for decoding how aberrant protein recycling leads to improper function and even death of cells in our body. He is executive committee member of ACMES and to cure autism institute.

Yiping Shen

Dr. Shen is Medical Director of Genetic Diagnostic Laboratory at Boston Children Hospital (now Claritas Genomics) and Assistant Professor of Harvard Medical School. He is a board certified in Clinical Molecular Geneticist. Dr. Shen is interested in identifying the genetic causes of autism and other neurodevelopmental disorders, translating the basic finding to improve patient care by providing genetic testing and counseling, as well as developing new management/treatment approaches.

Albert Yeung

Dr. Yeung is the current Director of Primary Care Research at Depression Clinical and Research Program, Massachusetts General Hospital, Associate Professor of Psychiatry, Harvard Medical School. Dr. Albert Yeung obtained his medical degree from National Taiwan University. He also obtained a Doctor of Science degree with a major in epidemiology from Harvard School of Public Health.  He completed residency training in psychiatry at the Massachusetts General Hospital (MGH). He has worked as a staff psychiatrist at MGH since completion of his residency training. Dr. Yeung's major research interests include integrating primary care and mental health services to improve treatment of depression, mental health issues of under-served populations, and the use of complementary and alternative methods in treating mood and anxiety disorders. He received a research training award from the Program for Minority Research Training in Psychiatry of the American Psychiatric Association Office of Research. In 2003, he was awarded a "Partners in Excellence Award" from Partners Health Care, Inc. for his contributions to a project on improving treatment for depressed patients in primary care.  He is the recipient of a Career Development Award (2003-2008), and a RO1 Research Award, both from the National Institute of Mental Health.  He has authored or co-authored over 50 original articles and book chapters, and a book on self-management of depression. Dr. Yeung is currently the Director of Primary Care Research at the Depression Clinical and Research Program at MGH, a consultant of the Benson Henry Institute at MGH, and Associate Professor of Psychiatry at Harvard Medical School. He is also a staff psychiatrist at the Behavioral Health Department of South Cove Community Health Center in Boston, which serves the Asian immigrant community. He is executive committee member of ACMES and To Cure Autism Institute, editor of North American Journal of Medicine and Science。

Peining Li

Peining Li is a Diplomate of the American Board of Medical Genetics and Genomics (ABMGG), a Fellow of the American College of Medical Genetics and Genomics (FACMG) and an elected Board Member (2011-2014) of the Association of Chinese Geneticists in America (ACGA). Dr. Li is ABMGG board certified in Clinical Molecular Genetics and Cytogenetics. His initial academic appointment (2003-2005) was clinical assistant professor and director of clinical cytogenetics laboratory in the Department of Pediatrics, School of Medicine, Washington University at St. Louis. His current appointment is associate professor and director of molecular cytogenetics and genomics laboratory in the Department of Genetics, Yale School of Medicine. Dr. Li’s laboratory provides chromosome testing and microarray analysis for prenatal, pediatric and cancer patients, performs translational genetic and genomic research and serves as a teaching unit for medical students, residents and fellows. He is executive committee member of ACMES and specialty editor of North American Journal of Medicine and Health, co-chief editor of its special genetic issue.

Jian Kong

Associate professor at Psychiatry Department, Massachusetts General Hospital, Harvard Medical School. In the past decades, his research interest has been focus on pain perception and modulation, alternative medicine (acupuncture, meditation) and placebo effect. He has published more than sixty papers in peer reviewed journals on these topics. He is executive committee member of ACMES and To cure autism institute, editor of North American Journal of Medicine and Science.

Rui Tan

 Professor of Xi Nan Jiao Tong University

Hao Wang

Dr.Wang obtained his MD degree from Peking Union Medical College in Beijing, China in 1998 and then graduated from Northwestern University in Evanston, IL with a PHD in cancer biology in 2004.   After that, I completed Internal Medicine residency training at Saint Louis University School of Medicine at Saint Louis, MO and Medical Oncology and Hematology fellowship at Yale-New Haven Hospital.  I joined Harvard Vanguard Medical Associates in 2010 and I am also a clinical instructor in medicine at Harvard Medical School. He is executive committee member, meeting moderator of ACMES.

Daryl Lau

Daryl Lau, MD, M.Sc, MPH: Dr. Lau is an Associate Professor of Medicine at Harvard Medical School (HMS) and serves as the Director of Translational Liver Research at Beth Israel Deaconess medical Center, HMS. Dr. Lau's major research interest has been the clinical and translational investigation of liver disease and in particularly viral hepatitis. She has conducted studies on the natural history and new therapeutic trials on hepatitis B, hepatitis C and delta hepatitis. She is the Program Director of the Harvard Hepatitis B Consortium, one of the clinical centers of the NIDDK-sponsored Hepatitis B Research Network. Her laboratory also serves as the Clinical Core for an NIAID sponsored Hepatitis C Center for the studies of innate immunity. Translational research projects in collaboration with basic scientists include the role of race and host genetic factors in determining interferon response in HCV infection using molecular, microarray techniques and microRNA technology.  Dr. Lau has been elected to “Best Doctors in America” in consecutive year since 2005. She serves as advisor and consultant for a number of national nonprofit organizations including Asian Health Foundation and Asian Pacific American Medical Students Association (APAMSA). She has numerous publications on viral hepatitis and liver diseases and serves in Editorial Board for a number of peer-review journals.